Related Experiment Video
Updated: Jun 15, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Essential thrombocythemia, unremarkable cause of atypical chest pain with simple yet effective treatment: a case
Kevin J Patel1, Amit Banga, Shahibzada U Latif
1Department of Medicine, Michigan State University, B301 MSU Clinical Center, 138 Service Road, East Lansing, MI 48824, USA. kpatel@msu.edu
Introduction:
The cause of chest pain in patients presenting to the emergency room often remains unclear. We present a case of essential thrombocythemia as a novel cause of atypical chest pain, which responded dramatically to a simple treatment intervention.
Case Presentation:
A 54-year-old patient presenting with atypical chest pain was found to have essential thrombocythemia as a cause for her chest pain. She responded dramatically to aspirin therapy and had no recurrence of symptoms over 3 months.
Conclusion:
Essential thrombocythemia should be considered as a differential cause in patient presenting with atypical chest pain, vasomotor symptoms and high platelet counts. These symptoms are generally more bothersome than dangerous and are usually controlled by low dose aspirin therapy.
Related Concept Videos
Pericarditis II: Clinical Features and Diagnostic Tests
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Venous Thrombosis III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pulmonary Embolism III: Nursing Management